| Ms Frances Pilar Garcia, MS/LADC | |
|
184 Front Ave, West Haven, CT 06516-2836 | |
| (203) 781-4600 | |
| (203) 781-4624 |
| Full Name | Ms Frances Pilar Garcia |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 184 Front Ave, West Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093945909 | NPI | - | NPPES |
| 008045323 | Medicaid | CT | |
| 008068631 | Medicaid | CT | |
| 008068669 | Medicaid | CT | |
| 008068749 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 000870 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Frances Pilar Garcia, MS/LADC 1 Long Wharf Dr, New Haven, CT 06511-5991 Ph: (203) 781-4600 | Ms Frances Pilar Garcia, MS/LADC 184 Front Ave, West Haven, CT 06516-2836 Ph: (203) 781-4600 |
News Archive
The European Patent Office has issued patent number EP2561103B1 for invention to BGI for its independently researched non-invasive prenatal genetic test (NIPT) technology. This technology has been developed by BGI in connection with the provision of its market leading NIPT, the NIFTY test.
Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SPRYCEL (dasatinib) Support, a useful resource to assist adult patients with chronic myeloid leukemia (CML) who are taking SPRYCEL.
Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs.
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.
› Verified 3 days ago
Mr. James Michael Aleksunes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 950 Campbell Ave, Ms 122v, West Haven, CT 06516 Phone: 203-932-5711 | |
Anokhi Patel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 20 Alling St, West Haven, CT 06516 Phone: 813-598-1317 | |
Jaylah Evans, LPCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 211 Homeside Ave, West Haven, CT 06516 Phone: 203-800-0647 | |
Marylou Duggan, Counselor Medicare: Not Enrolled in Medicare Practice Location: 114 Boston Post Rd, West Haven, CT 06516 Phone: 203-506-4133 Fax: 203-931-4068 | |
Natalie Deandrea, Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Elm St, West Haven, CT 06516 Phone: 203-933-8050 | |
John David Lieberman, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 415 Main St, West Haven, CT 06516 Phone: 203-931-1184 Fax: 203-931-0063 | |
Carlie Dackson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 415 Main St, West Haven, CT 06516 Phone: 203-934-1184 Fax: 475-234-0805 |